Purple Finance Ltd leads losers in ‘B’ group
3 months ago•Business Standard
Tatva Chintan Pharma Chem consolidated net profit declines 45.16% in the June 2024 quarter
3 months ago•Business Standard
Tatva Chintan Q4 Results Review - Revenue May Rise 25% With Expansion In Margin: ICICI Securities
6 months ago•Bloomberg Quint
Tatva Chintan - Delay In EU 7 Implementation Poses Risk To SDA Growth: Nirmal Bang
7 months ago•Bloomberg Quint
Accumulate Tatva Chintan Pharma Chem; target of Rs 1487: KR Choksey
9 months ago•Moneycontrol
Tatva Chintan gains after fixing floor price of Rs 1704.74 a share for QIP
1 year ago•Moneycontrol
Key Stocks In Focus: Paytm, Amber Enterprises, Tatva Chintan Pharma, Aurobindo Pharma, GIC RE, BEL
1 year ago•CNBC-TV18